参考文献/References:
[1] 马明铭,李 芳,杨 慧,等.噻托溴胺粉雾剂联合非药物康复方案对慢性阻塞性肺疾病患者BODE指数的影响[J].陕西医学杂志, 2019,48(4):515-517.
[2] Gadre SK,Duggal A,Mireles CE,et al.Acute respiratory failure requiring mechanical ventilation in severe chronic obstructive pulmonary disease [J].Medicine,2018,97(17):487-493.
[3] Osadnik C,Tee V,Carson K,et al.Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease:a cochrane review update[J].Cochrane Database Syst Rev,2017,7(7):4104-4110.
[4] 王建华,胡贵芳,蒋世碧,等.无创机械通气对慢性阻塞性肺疾病合并呼吸衰竭患者睡眠、认知功能的影响[J].国际呼吸杂志,2018,38(19):1465-1469.
[5] 陈家兵.无创呼吸机治疗慢性阻塞性肺疾病合并呼吸衰竭的临床分析[J].深圳中西医结合杂志,2017,27(19):122-123.
[6] Sellares J,Ferrer M,Anton A,et al.Discontinuing noninvasive ventilation in severe chronic obstructive pulmonary disease exacerbations:a randomised controlled trial[J].Eur Respir J,2017,50(1):1601-1608.
[7] 苟 萍.中西医结合治疗慢性阻塞性肺疾病合并呼吸衰竭的疗效分析[J].中医临床研究,2019,11(10):76-77.
[8] 王海峰,张海龙.中西医结合治疗对急性加重期重症慢性阻塞性肺疾病患者CRP和T细胞亚群的影响[J].中医学报,2017,32(12):2320-2322.
[9] Leyba CO,Montejo JC,Gonzalez CV.Guidelines for specialized nutritional and metabolic support in the critically-ill patient consensus semicyuc-senpe:septic patient[J].Nutrición Hospitalaria,2011,26(2):37-40.
[10] 中华医学会,中华医学会杂志社,中华医学会全科医学分会,等.慢性阻塞性肺疾病基层诊疗指南[J].中华全科医师杂志,2018,17(11):856-870.
[11] Schopfer L,Groenendijk L,Janssens JP,et al.Long-term non-invasive ventilation in chronic obstructive pulmonary disease patients[J].Rev Med Suisse,2018,592(14):283-288.
[12] 林敬明,陈文丽,郑辉才,等.对比布地奈德福莫特罗与氨茶碱治疗缓解期COPD的疗效及对患者血气指标、肺功能影响[J].中国急救复苏与灾害医学杂志,2019,14(7):635-638.
[13] Stephens AR,Wiener RS,Ieong MH.Comparison of methods to identify advance care planning in patients with severe chronic obstructive pulmonary disease exacerbation[J].J Palliat Med,2017,21(3):284-289.
[14] Leitao FS,Alotaibi NM,Yamasaki K,et al.The role of beta-blockers in the management of chronic obstructive pulmonary disease[J].Expert Rev Respir Med,2017,12(2):125-135.
[15] 贾钦尧,宋 珊,韩美玲,等.无创呼吸机在慢性阻塞性肺疾病合并呼吸衰竭患者中的应用效果及对炎症因子的影响[J].国际医药卫生导报,2017,27(12):1891-1894.
[16] 刘 泉,蒋心悦,郑 敏.压力调节容积控制通气模式治疗慢性阻塞性肺疾病急性加重期并发呼吸衰竭的临床疗效[J].医学综述,2019,23(15):3116-3120.
[17] Yeh GY,Horwitz R.Integrative medicine for respiratory conditions:asthma and chronic obstructive pulmonary disease[J].Med Clin North Am,2017,101(5):925-941.
[18] 李士瑾.中医辨证治疗慢性阻塞性肺疾病合并呼吸衰竭临床观察[J].实用中西医结合临床,2018,18(6):74-76.
[19] 李 彬,白辉辉.半夏厚朴汤对痰湿阻肺型慢性阻塞性肺疾病急性期肺功能及微观指标的影响[J].陕西中医,2019,40(4):466-468.
[20] 胡晓玲,崔红生.益气化痰通络方治疗老年中重度慢性阻塞性肺疾病的临床疗效观察[J].世界中西医结合杂志,2017,12(11):1580-1583.
[21] 丁宪春.解毒化痰平喘汤治疗慢性阻塞性肺疾病急性加重期的临床观察[J].中国中医药科技,2019,26(2):312-314.
[22] 程 茹,张明华,俞万钧.通腑平喘汤对老年慢性阻塞性肺疾病合并呼吸衰竭的疗效及FVC、FEV1/FVC水平的影响[J].中华中医药学刊,2018,36(7):1653-1656.
[23] Zheng J,Shi Y,Xiong L,et al.The expression of IL-6 TNF-α and MCP-1 in respiratory viral infection in acute exacerbations of chronic obstructive pulmonary disease[J].J Immunol Res,2017,17(5):853-859.
[24] Lin YH,Liao XN,Fan LL,et al.Long-term treatment with budesonide/formoterol attenuates circulating CRP levels in chronic obstructive pulmonary disease patients of group[J].Plos One,2017,12(8):183-187.
[25] Zhang J,Bai C.The significance of serum interleukin-8 in acute exacerbations of chronic obstructive pulmonary disease[J].Tanaffos,2018,17(1):13-21.
[26] 王新杰.COPD急性加重期和稳定期患者的肺功能评估及其与血清促炎因子、趋化因子的相关性[J].海南医学院学报,2016,22(21):2629-2632.
相似文献/References:
[1]任素霞,陶赟臻△,张美玲.益气消癥通络方联合西药对慢性阻塞性肺疾病急性加重期患者BODE指数及CRP的影响[J].陕西中医,2020,(7):920.[doi:DOI:10.3969/j.issn.10007369.2020.07.024]
[2]杨艳菁,蒋 玲△,李 霞.益气通络消癥汤对慢性阻塞性肺疾病患者肺功能及血清sICAM-1、MMP-9水平的影响*[J].陕西中医,2020,(9):1225.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.013]
[3]陈辅萍,彭 琦△.肺力咳胶囊联合沙丁胺醇治疗慢性阻塞性肺疾病疗效及对患者肺功能的影响[J].陕西中医,2020,(9):1228.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.014]
CHEN Fuping,PENG Qi..Effect of Feilike capsule combined with salbutamol on chronic obstructive pulmonary disease and pulmonary function[J].,2020,(12):1228.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.014]
[4]翟豫疆,苏 军,梁丽丽,等.滋阴利肺汤治疗肺结核合并慢性阻塞性肺疾病疗效及对患者肺泡巨噬细胞分泌细胞因子水平的影响[J].陕西中医,2021,(8):1041.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.013]
ZHAI Yujiang,SU Jun,LIANG Lili,et al.Effect of Ziyin Lifei decoction in the auxiliary treatment of pulmonary tuberculosis patients with chronic obstructive pulmonary disease and its effect on the secretion of cytokines by alveolar macrophages[J].,2021,(12):1041.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.013]
[5]李竹英,陈 璐,王丽洁.麻黄-白果药对“异病同治”支气管哮喘和慢性阻塞性肺疾病药理作用研究[J].陕西中医,2021,(8):1128.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.035]
LI Zhuying,CHEN Lu,WANG Lijie.Pharmacological mechanism of Ephedra and Ginkgo couplet medicine in treating asthma and COPD based on treating different diseases with the same treatment[J].,2021,(12):1128.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.035]
[6]孙境孺,李竹英.NF-κB信号通路在肺部疾病中的作用研究进展及中医药干预现状[J].陕西中医,2022,(7):972.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.039]
SUN Jingru,LI Zhuying.Research progress of role of NF-κB signaling pathway in lung diseases and the current situation of traditional Chinese medicine intervention[J].,2022,(12):972.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.039]